10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VB0 (Viva Biotech Holdings) Stock Analysis
Buy, Hold or Sell?

Let's analyze Viva Biotech Holdings together

I guess you are interested in Viva Biotech Holdings. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Viva Biotech Holdings’s Financial Insights
  • 📈 Technical Analysis (TA) – Viva Biotech Holdings’s Price Targets

I'm going to help you getting a better view of Viva Biotech Holdings. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Viva Biotech Holdings

I send you an email if I find something interesting about Viva Biotech Holdings.

1. Quick Overview

1.1. Quick analysis of Viva Biotech Holdings (30 sec.)










1.2. What can you expect buying and holding a share of Viva Biotech Holdings? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
55.6%

What is your share worth?

Current worth
€0.21
Expected worth in 1 year
€0.25
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
€0.03
Return On Investment
12.5%

For what price can you sell your share?

Current Price per Share
€0.27
Expected price per share
€0.21 - €0.314
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Viva Biotech Holdings (5 min.)




Live pricePrice per Share (EOD)
€0.27
Intrinsic Value Per Share
€0.04 - €0.43
Total Value Per Share
€0.25 - €0.64

2.2. Growth of Viva Biotech Holdings (5 min.)




Is Viva Biotech Holdings growing?

Current yearPrevious yearGrowGrow %
How rich?$537.3m$519.2m$18m3.4%

How much money is Viva Biotech Holdings making?

Current yearPrevious yearGrowGrow %
Making money$23.5m-$16.3m$39.9m169.4%
Net Profit Margin8.4%-5.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Viva Biotech Holdings (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Viva Biotech Holdings?

Welcome investor! Viva Biotech Holdings's management wants to use your money to grow the business. In return you get a share of Viva Biotech Holdings.

First you should know what it really means to hold a share of Viva Biotech Holdings. And how you can make/lose money.

Speculation

The Price per Share of Viva Biotech Holdings is €0.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Viva Biotech Holdings.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Viva Biotech Holdings, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.21. Based on the TTM, the Book Value Change Per Share is €0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Viva Biotech Holdings.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.014.1%0.014.1%-0.01-2.8%-0.01-3.9%-0.01-2.8%0.00-0.3%
Usd Book Value Change Per Share0.013.7%0.013.7%0.001.5%0.00-0.8%0.0310.0%0.0310.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.3%0.000.3%
Usd Total Gains Per Share0.013.7%0.013.7%0.001.5%0.00-0.8%0.0310.3%0.0310.7%
Usd Price Per Share0.12-0.12-0.13-0.16-0.43-0.30-
Price to Earnings Ratio10.90-10.90--17.19--4.35--4.71-1.18-
Price-to-Total Gains Ratio12.05-12.05-32.93-11.13-18.51-16.41-
Price to Book Ratio0.48-0.48-0.54-0.67-1.71-1.52-
Price-to-Total Gains Ratio12.05-12.05-32.93-11.13-18.51-16.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.319194
Number of shares3132
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.010.03
Gains per Quarter (3132 shares)31.3487.30
Gains per Year (3132 shares)125.37349.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1012511511338339
2025124023676688
303763653410141037
405014904513521386
506276155616901735
607527406820282084
708788657923662433
8010039909027032782
901128111510230413131
1001254124011333793480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.03.00.066.7%6.03.00.066.7%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%5.00.04.055.6%5.00.04.055.6%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Viva Biotech Holdings compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0080.0080%0.003+151%-0.002+121%0.023-63%0.024-64%
Book Value Per Share--0.2140.2140%0.205+4%0.207+3%0.210+2%0.131+63%
Current Ratio--1.6661.6660%1.324+26%1.238+35%2.082-20%4.149-60%
Debt To Asset Ratio--0.4590.4590%0.505-9%0.503-9%0.512-10%0.405+13%
Debt To Equity Ratio--0.8510.8510%1.020-17%1.023-17%1.059-20%0.792+7%
Dividend Per Share----0%-0%-0%0.001-100%0.001-100%
Enterprise Value---168113969.196-168113969.1960%-210318140.145+25%-155599504.014-7%295617043.418-157%424499732.427-140%
Eps--0.0090.0090%-0.006+169%-0.009+195%-0.006+169%-0.001+108%
Ev To Sales Ratio---0.711-0.7110%-0.819+15%-0.614-14%3.410-121%7.471-110%
Free Cash Flow Per Share--0.0100.0100%0.011-6%0.010+7%-0.006+162%-0.004+141%
Free Cash Flow To Equity Per Share--0.0100.0100%0.011-6%0.007+48%0.044-77%0.035-71%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.429----------
Intrinsic Value_10Y_min--0.036----------
Intrinsic Value_1Y_max--0.017----------
Intrinsic Value_1Y_min---0.004----------
Intrinsic Value_3Y_max--0.070----------
Intrinsic Value_3Y_min---0.005----------
Intrinsic Value_5Y_max--0.148----------
Intrinsic Value_5Y_min--0.000----------
Market Cap574676087.040+62%217099855.104217099855.1040%237736059.855-9%293507301.786-26%768233593.718-72%547170979.351-60%
Net Profit Margin--0.0840.0840%-0.054+164%-0.064+176%-0.122+245%0.157-46%
Operating Margin----0%-0%-0%0.055-100%0.152-100%
Operating Ratio--1.5181.5180%1.539-1%1.528-1%1.505+1%1.381+10%
Pb Ratio1.264+62%0.4780.4780%0.541-12%0.670-29%1.707-72%1.517-69%
Pe Ratio28.842+62%10.89610.8960%-17.191+258%-4.353+140%-4.715+143%1.182+822%
Price Per Share0.270+62%0.1020.1020%0.111-8%0.138-26%0.361-72%0.257-60%
Price To Free Cash Flow Ratio26.465+62%9.9989.9980%10.207-2%15.463-35%0.187+5255%-63.804+738%
Price To Total Gains Ratio31.897+62%12.05012.0500%32.933-63%11.134+8%18.515-35%16.413-27%
Quick Ratio--0.3720.3720%0.257+45%0.264+41%0.350+6%0.895-58%
Return On Assets--0.0240.0240%-0.016+166%-0.020+182%-0.014+159%0.095-75%
Return On Equity--0.0440.0440%-0.031+172%-0.045+202%-0.033+174%0.129-66%
Total Gains Per Share--0.0080.0080%0.003+151%-0.002+121%0.024-64%0.024-65%
Usd Book Value--537323993.124537323993.1240%519258083.358+3%521375293.259+3%528817672.556+2%329114320.883+63%
Usd Book Value Change Per Share--0.0100.0100%0.004+151%-0.002+121%0.027-63%0.028-64%
Usd Book Value Per Share--0.2520.2520%0.242+4%0.244+3%0.248+2%0.154+63%
Usd Dividend Per Share----0%-0%-0%0.001-100%0.001-100%
Usd Enterprise Value---198744334.384-198744334.3840%-248638105.279+25%-183949733.645-7%349478468.729-157%501843583.675-140%
Usd Eps--0.0110.0110%-0.008+169%-0.011+195%-0.008+169%-0.001+108%
Usd Free Cash Flow--25670518.84625670518.8460%27536119.111-7%24142369.296+6%-15763829.439+161%-9409117.781+137%
Usd Free Cash Flow Per Share--0.0120.0120%0.013-6%0.011+7%-0.007+162%-0.005+141%
Usd Free Cash Flow To Equity Per Share--0.0120.0120%0.013-6%0.008+48%0.052-77%0.042-71%
Usd Market Cap679382070.099+62%256655448.704256655448.7040%281051569.961-9%346984332.172-26%908205754.494-72%646865531.789-60%
Usd Price Per Share0.319+62%0.1210.1210%0.131-8%0.163-26%0.427-72%0.304-60%
Usd Profit--23554998.54623554998.5460%-16348712.722+169%-22401001.582+195%-16237846.787+169%-1869088.977+108%
Usd Revenue--279720500.533279720500.5330%303505425.512-8%306092672.812-9%262532929.452+7%158020300.491+77%
Usd Total Gains Per Share--0.0100.0100%0.004+151%-0.002+121%0.028-64%0.029-65%
 EOD+4 -4MRQTTM+0 -0YOY+24 -113Y+27 -85Y+18 -2010Y+12 -26

3.3 Fundamental Score

Let's check the fundamental score of Viva Biotech Holdings based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1528.842
Price to Book Ratio (EOD)Between0-11.264
Net Profit Margin (MRQ)Greater than00.084
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.372
Current Ratio (MRQ)Greater than11.666
Debt to Asset Ratio (MRQ)Less than10.459
Debt to Equity Ratio (MRQ)Less than10.851
Return on Equity (MRQ)Greater than0.150.044
Return on Assets (MRQ)Greater than0.050.024
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Viva Biotech Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.877
Ma 20Greater thanMa 500.280
Ma 50Greater thanMa 1000.228
Ma 100Greater thanMa 2000.203
OpenGreater thanClose0.270
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Viva Biotech Holdings

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions. It also offers PROTAC/molecular glue services, including protein preparation and ternary complex structure determination, screening for molecule glues and novel E3 ligase ligands, PROTAC ternary complex kinetics, PROTAC degradation assays and ternary complex assays, PROTAC molecule design and synthesis, ADME & PK/PD studies of PROTAC molecules, and computer aided PROTAC design solutions; and XDC platforms, such as XDC conjugation and quality study, XDC chemistry research and development, and XDC functional studies. In addition, the company offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and other services. Further, it provides research services. The company was incorporated in 2008 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2025-08-21 04:06:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Viva Biotech Holdings earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • A Net Profit Margin of 8.4% means that €0.08 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Viva Biotech Holdings:

  • The MRQ is 8.4%. The company is making a profit. +1
  • The TTM is 8.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.4%TTM8.4%0.0%
TTM8.4%YOY-5.4%+13.8%
TTM8.4%5Y-12.2%+20.6%
5Y-12.2%10Y15.7%-27.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4%-85.5%+93.9%
TTM8.4%-171.0%+179.4%
YOY-5.4%-210.0%+204.6%
3Y-6.4%-289.9%+283.5%
5Y-12.2%-381.1%+368.9%
10Y15.7%-520.3%+536.0%
4.3.1.2. Return on Assets

Shows how efficient Viva Biotech Holdings is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • 2.4% Return on Assets means that Viva Biotech Holdings generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Viva Biotech Holdings:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY-1.6%+3.9%
TTM2.4%5Y-1.4%+3.8%
5Y-1.4%10Y9.5%-10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%-11.9%+14.3%
TTM2.4%-11.9%+14.3%
YOY-1.6%-11.2%+9.6%
3Y-2.0%-12.0%+10.0%
5Y-1.4%-11.7%+10.3%
10Y9.5%-13.8%+23.3%
4.3.1.3. Return on Equity

Shows how efficient Viva Biotech Holdings is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • 4.4% Return on Equity means Viva Biotech Holdings generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Viva Biotech Holdings:

  • The MRQ is 4.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY-3.1%+7.5%
TTM4.4%5Y-3.3%+7.7%
5Y-3.3%10Y12.9%-16.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%-14.2%+18.6%
TTM4.4%-15.2%+19.6%
YOY-3.1%-15.3%+12.2%
3Y-4.5%-16.9%+12.4%
5Y-3.3%-17.5%+14.2%
10Y12.9%-19.6%+32.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Viva Biotech Holdings.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Viva Biotech Holdings is operating .

  • Measures how much profit Viva Biotech Holdings makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Viva Biotech Holdings:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.5%-5.5%
5Y5.5%10Y15.2%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM--280.2%+280.2%
YOY--268.7%+268.7%
3Y--281.5%+281.5%
5Y5.5%-350.8%+356.3%
10Y15.2%-530.7%+545.9%
4.3.2.2. Operating Ratio

Measures how efficient Viva Biotech Holdings is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are €1.52 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Viva Biotech Holdings:

  • The MRQ is 1.518. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.518. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.518TTM1.5180.000
TTM1.518YOY1.539-0.020
TTM1.5185Y1.505+0.013
5Y1.50510Y1.381+0.124
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5181.952-0.434
TTM1.5182.974-1.456
YOY1.5393.047-1.508
3Y1.5283.835-2.307
5Y1.5054.924-3.419
10Y1.3816.864-5.483
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Viva Biotech Holdings.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Viva Biotech Holdings is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.67 means the company has €1.67 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Viva Biotech Holdings:

  • The MRQ is 1.666. The company is able to pay all its short-term debts. +1
  • The TTM is 1.666. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.666TTM1.6660.000
TTM1.666YOY1.324+0.342
TTM1.6665Y2.082-0.417
5Y2.08210Y4.149-2.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6663.480-1.814
TTM1.6663.790-2.124
YOY1.3244.104-2.780
3Y1.2384.609-3.371
5Y2.0825.764-3.682
10Y4.1496.154-2.005
4.4.3.2. Quick Ratio

Measures if Viva Biotech Holdings is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • A Quick Ratio of 0.37 means the company can pay off €0.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Viva Biotech Holdings:

  • The MRQ is 0.372. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.372. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.3720.000
TTM0.372YOY0.257+0.115
TTM0.3725Y0.350+0.021
5Y0.35010Y0.895-0.545
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3722.938-2.566
TTM0.3723.291-2.919
YOY0.2573.928-3.671
3Y0.2644.393-4.129
5Y0.3505.837-5.487
10Y0.8956.549-5.654
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Viva Biotech Holdings.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Viva Biotech Holdings assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Viva Biotech Holdings to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that Viva Biotech Holdings assets are financed with 45.9% credit (debt) and the remaining percentage (100% - 45.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Viva Biotech Holdings:

  • The MRQ is 0.459. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.459. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.459TTM0.4590.000
TTM0.459YOY0.505-0.046
TTM0.4595Y0.512-0.054
5Y0.51210Y0.405+0.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4590.339+0.120
TTM0.4590.359+0.100
YOY0.5050.334+0.171
3Y0.5030.341+0.162
5Y0.5120.349+0.163
10Y0.4050.379+0.026
4.5.4.2. Debt to Equity Ratio

Measures if Viva Biotech Holdings is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • A Debt to Equity ratio of 85.1% means that company has €0.85 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Viva Biotech Holdings:

  • The MRQ is 0.851. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.851. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.851TTM0.8510.000
TTM0.851YOY1.020-0.169
TTM0.8515Y1.059-0.208
5Y1.05910Y0.792+0.267
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8510.391+0.460
TTM0.8510.436+0.415
YOY1.0200.436+0.584
3Y1.0230.461+0.562
5Y1.0590.461+0.598
10Y0.7920.514+0.278
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Viva Biotech Holdings generates.

  • Above 15 is considered overpriced but always compare Viva Biotech Holdings to the Biotechnology industry mean.
  • A PE ratio of 10.90 means the investor is paying €10.90 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Viva Biotech Holdings:

  • The EOD is 28.842. Based on the earnings, the company is overpriced. -1
  • The MRQ is 10.896. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.896. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD28.842MRQ10.896+17.946
MRQ10.896TTM10.8960.000
TTM10.896YOY-17.191+28.087
TTM10.8965Y-4.715+15.611
5Y-4.71510Y1.182-5.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD28.842-2.539+31.381
MRQ10.896-2.361+13.257
TTM10.896-2.657+13.553
YOY-17.191-3.749-13.442
3Y-4.353-3.883-0.470
5Y-4.715-6.353+1.638
10Y1.182-7.102+8.284
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Viva Biotech Holdings:

  • The EOD is 26.465. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 9.998. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.998. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD26.465MRQ9.998+16.467
MRQ9.998TTM9.9980.000
TTM9.998YOY10.207-0.209
TTM9.9985Y0.187+9.811
5Y0.18710Y-63.804+63.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD26.465-3.411+29.876
MRQ9.998-2.951+12.949
TTM9.998-3.614+13.612
YOY10.207-4.421+14.628
3Y15.463-5.258+20.721
5Y0.187-8.587+8.774
10Y-63.804-9.639-54.165
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Viva Biotech Holdings is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.48 means the investor is paying €0.48 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Viva Biotech Holdings:

  • The EOD is 1.264. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.478. Based on the equity, the company is cheap. +2
  • The TTM is 0.478. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.264MRQ0.478+0.787
MRQ0.478TTM0.4780.000
TTM0.478YOY0.541-0.064
TTM0.4785Y1.707-1.229
5Y1.70710Y1.517+0.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2642.206-0.942
MRQ0.4782.027-1.549
TTM0.4782.194-1.716
YOY0.5412.425-1.884
3Y0.6702.571-1.901
5Y1.7073.805-2.098
10Y1.5174.462-2.945
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,050,594
Total Liabilities3,234,373
Total Stockholder Equity3,802,377
 As reported
Total Liabilities 3,234,373
Total Stockholder Equity+ 3,802,377
Total Assets = 7,050,594

Assets

Total Assets7,050,594
Total Current Assets1,876,598
Long-term Assets5,173,996
Total Current Assets
Cash And Cash Equivalents 941,581
Net Receivables 418,949
Inventory 272,700
Total Current Assets  (as reported)1,876,598
Total Current Assets  (calculated)1,633,230
+/- 243,368
Long-term Assets
Property Plant Equipment 1,606,609
Goodwill 2,156,419
Intangible Assets 366,049
Long-term Assets  (as reported)5,173,996
Long-term Assets  (calculated)4,129,077
+/- 1,044,919

Liabilities & Shareholders' Equity

Total Current Liabilities1,126,655
Long-term Liabilities2,107,718
Total Stockholder Equity3,802,377
Total Current Liabilities
Short Long Term Debt 549,390
Accounts payable 309,355
Total Current Liabilities  (as reported)1,126,655
Total Current Liabilities  (calculated)858,745
+/- 267,910
Long-term Liabilities
Long term Debt 705,921
Capital Lease Obligations Min Short Term Debt28,740
Long-term Liabilities  (as reported)2,107,718
Long-term Liabilities  (calculated)734,661
+/- 1,373,057
Total Stockholder Equity
Total Stockholder Equity (as reported)3,802,377
Total Stockholder Equity (calculated)0
+/- 3,802,377
Other
Capital Stock367
Common Stock Shares Outstanding 2,113,162
Net Debt 313,730
Net Invested Capital 5,057,688
Net Working Capital 749,943
Property Plant and Equipment Gross 2,154,856



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
101,821
202,402
529,339
1,898,785
8,154,080
8,044,758
7,920,855
7,449,912
7,050,594
7,050,5947,449,9127,920,8558,044,7588,154,0801,898,785529,339202,402101,821
   > Total Current Assets 
65,164
83,447
241,170
1,094,426
3,351,544
1,983,785
1,938,807
2,030,918
1,876,598
1,876,5982,030,9181,938,8071,983,7853,351,5441,094,426241,17083,44765,164
       Cash And Cash Equivalents 
13,425
29,766
155,554
904,091
2,308,452
800,947
678,569
1,036,322
941,581
941,5811,036,322678,569800,9472,308,452904,091155,55429,76613,425
       Short-term Investments 
0
3,500
0
29,629
49,500
0
0
0
0
000049,50029,62903,5000
       Net Receivables 
42,539
33,034
58,253
68,011
321,571
423,010
432,486
394,549
418,949
418,949394,549432,486423,010321,57168,01158,25333,03442,539
       Inventory 
1,013
3,323
4,900
8,530
164,745
231,721
326,031
259,707
272,700
272,700259,707326,031231,721164,7458,5304,9003,3231,013
       Other Current Assets 
6,782
11,856
19,555
82,822
419,847
411,954
420,883
0
0
00420,883411,954419,84782,82219,55511,8566,782
   > Long-term Assets 
36,657
118,955
288,169
804,359
4,802,536
6,060,973
5,982,048
5,418,994
5,173,996
5,173,9965,418,9945,982,0486,060,9734,802,536804,359288,169118,95536,657
       Property Plant Equipment 
21,343
34,400
66,899
156,986
737,010
1,723,901
1,964,417
1,660,938
1,606,609
1,606,6091,660,9381,964,4171,723,901737,010156,98666,89934,40021,343
       Goodwill 
0
0
0
0
1,847,723
2,156,419
2,156,419
2,156,419
2,156,419
2,156,4192,156,4192,156,4192,156,4191,847,7230000
       Intangible Assets 
0
0
0
0
469,462
531,444
476,061
420,669
366,049
366,049420,669476,061531,444469,4620000
       Other Assets 
3,192
6,986
11,253
20,291
823,809
402,479
0
0
0
000402,479823,80920,29111,2536,9863,192
> Total Liabilities 
25,319
49,640
277,897
121,391
4,397,249
4,131,402
4,316,141
3,762,000
3,234,373
3,234,3733,762,0004,316,1414,131,4024,397,249121,391277,89749,64025,319
   > Total Current Liabilities 
16,320
36,991
42,462
72,963
735,672
926,603
2,672,557
1,534,178
1,126,655
1,126,6551,534,1782,672,557926,603735,67272,96342,46236,99116,320
       Short Long Term Debt 
447
12,583
497
525
155,554
233,052
1,913,910
949,512
549,390
549,390949,5121,913,910233,052155,55452549712,583447
       Accounts payable 
1,575
3,767
4,685
7,552
295,704
281,053
326,130
245,756
309,355
309,355245,756326,130281,053295,7047,5524,6853,7671,575
       Other Current Liabilities 
9,198
13,842
31,027
19,685
125,321
300,956
0
0
0
000300,956125,32119,68531,02713,8429,198
   > Long-term Liabilities 
8,999
12,649
235,435
48,428
3,661,577
3,204,799
1,643,584
2,227,822
2,107,718
2,107,7182,227,8221,643,5843,204,7993,661,57748,428235,43512,6498,999
       Long term Debt 
2,833
2,362
1,865
1,340
2,798,634
2,388,179
880,959
922,012
705,921
705,921922,012880,9592,388,1792,798,6341,3401,8652,3622,833
       Capital Lease Obligations Min Short Term Debt
226
0
0
47,542
15,323
33,466
28,071
31,693
28,740
28,74031,69328,07133,46615,32347,54200226
       Other Liabilities 
6,166
10,287
12,970
24,004
859,031
788,846
0
0
0
000788,846859,03124,00412,97010,2876,166
       Long-term Liabilities Other 
0
0
0
0
516,846
542,041
571,500
0
0
00571,500542,041516,8460000
> Total Stockholder Equity
76,502
152,762
251,442
1,777,394
3,756,831
3,913,356
3,604,714
3,687,912
3,802,377
3,802,3773,687,9123,604,7143,913,3563,756,8311,777,394251,442152,76276,502
   Common Stock
120
120
164
261
323
326
0
0
0
000326323261164120120
   Retained Earnings 
17,204
93,464
183,542
449,414
62,534
350,080
-178,395
-418,521
-286,315
-286,315-418,521-178,395350,08062,534449,414183,54293,46417,204
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
45,588
45,588
20,485
29,046
95,896
60,651
280,484
0
0
00280,48460,65195,89629,04620,48545,58845,588



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,986,651
Cost of Revenue-1,299,252
Gross Profit687,399687,399
 
Operating Income (+$)
Gross Profit687,399
Operating Expense-1,717,062
Operating Income269,589-1,029,663
 
Operating Expense (+$)
Research Development87,986
Selling General Administrative364,122
Selling And Marketing Expenses-
Operating Expense1,717,062452,108
 
Net Interest Income (+$)
Interest Income20,539
Interest Expense-53,892
Other Finance Cost-0
Net Interest Income-33,353
 
Pretax Income (+$)
Operating Income269,589
Net Interest Income-33,353
Other Non-Operating Income Expenses-
Income Before Tax (EBT)295,705269,589
EBIT - interestExpense = -53,892
167,294
221,186
Interest Expense53,892
Earnings Before Interest and Taxes (EBIT)-349,597
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax295,705
Tax Provision-73,718
Net Income From Continuing Ops221,987221,987
Net Income167,294
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-33,353
 

Technical Analysis of Viva Biotech Holdings
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Viva Biotech Holdings. The general trend of Viva Biotech Holdings is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Viva Biotech Holdings's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Viva Biotech Holdings Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Viva Biotech Holdings.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.314.

The bearish price targets are: 0.252 > 0.242 > 0.21.

Know someone who trades $VB0? Share this with them.👇

Viva Biotech Holdings Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Viva Biotech Holdings. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Viva Biotech Holdings Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Viva Biotech Holdings. The current macd is 0.01352449.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Viva Biotech Holdings price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Viva Biotech Holdings. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Viva Biotech Holdings price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Viva Biotech Holdings Daily Moving Average Convergence/Divergence (MACD) ChartViva Biotech Holdings Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Viva Biotech Holdings. The current adx is 27.73.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Viva Biotech Holdings shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Viva Biotech Holdings Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Viva Biotech Holdings. The current sar is 0.30712897.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Viva Biotech Holdings Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Viva Biotech Holdings. The current rsi is 51.88. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Viva Biotech Holdings Daily Relative Strength Index (RSI) ChartViva Biotech Holdings Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Viva Biotech Holdings. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Viva Biotech Holdings price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Viva Biotech Holdings Daily Stochastic Oscillator ChartViva Biotech Holdings Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Viva Biotech Holdings. The current cci is -54.1089566.

Viva Biotech Holdings Daily Commodity Channel Index (CCI) ChartViva Biotech Holdings Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Viva Biotech Holdings. The current cmo is -7.7203382.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Viva Biotech Holdings Daily Chande Momentum Oscillator (CMO) ChartViva Biotech Holdings Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Viva Biotech Holdings. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Viva Biotech Holdings Daily Williams %R ChartViva Biotech Holdings Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Viva Biotech Holdings.

Viva Biotech Holdings Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Viva Biotech Holdings. The current atr is 0.01014099.

Viva Biotech Holdings Daily Average True Range (ATR) ChartViva Biotech Holdings Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Viva Biotech Holdings. The current obv is -23,757.

Viva Biotech Holdings Daily On-Balance Volume (OBV) ChartViva Biotech Holdings Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Viva Biotech Holdings. The current mfi is 64.02.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Viva Biotech Holdings Daily Money Flow Index (MFI) ChartViva Biotech Holdings Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Viva Biotech Holdings.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-06 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-03 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-07 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-17 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-29 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-31 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-01 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-07 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-20 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-02 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-04 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-11 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Viva Biotech Holdings Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Viva Biotech Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.877
Ma 20Greater thanMa 500.280
Ma 50Greater thanMa 1000.228
Ma 100Greater thanMa 2000.203
OpenGreater thanClose0.270
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Viva Biotech Holdings with someone you think should read this too:
  • Are you bullish or bearish on Viva Biotech Holdings? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Viva Biotech Holdings? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Viva Biotech Holdings

I send you an email if I find something interesting about Viva Biotech Holdings.


Comments

How you think about this?

Leave a comment

Stay informed about Viva Biotech Holdings.

Receive notifications about Viva Biotech Holdings in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.